Molecular Templates
Latest round
- Series D
Last raised
- Dec 2015
Total raised
- $18M
Investors
- 3
About Molecular Templates
Based in the US, Molecular Templates, Inc.Molecular Templates, Inc. is a clinical-stage biopharmaceutical firm dedicated to innovating therapeutic solutions for oncology. Established in 2001, the company is headquartered in Austin, Texas. The CEO, Eric Poma, has a background in biopharmaceuticals and previously co-founded other ventures.Molecular Templates, Inc. focuses on engineered toxin bodies (ETBs), which aim to specifically target and destroy cancer cells while preserving healthy tissue.In the fiscal year 2022, Molecular Templates, Inc.23 mn.Molecular Templates, Inc. is strategizing for future growth by advancing its clinical product candidates and exploring new geographic markets. The funds from the recent PIPE deal will support these initiatives, including the development of new ETB therapies. The company aims to enhance its market presence in Europe while leveraging existing partnerships to expedite clinical advancements.6 million shares for USD 43 mn, will be pivotal in driving these objectives forward.
Who invested in Molecular Templates
3 investors across 5 rounds
See all investors in Molecular Templates
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Molecular Templates
Who invested in Molecular Templates?
Molecular Templates has 3 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Molecular Templates raised?
Molecular Templates has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Molecular Templates last raise money?
Molecular Templates's most recent round on record is a Series D, in Dec 2015.
What does Molecular Templates do?
Based in the US, Molecular Templates, Inc.
Where is Molecular Templates headquartered?
Molecular Templates is headquartered in Austin, US.
Which VCs invest in companies like Molecular Templates?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Molecular Templates's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Molecular Templates? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.